INNATE PHARMA Aktie
| 1,50EUR | -0,05EUR | -3,47% |
WKN DE: A0LCUJ / ISIN: FR0010331421
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 68,24 |
| Novo Nordisk A/S | 12,13 |
| AstraZeneca PLC | 9,25 |
| Bpifrance Participations SA /PRIVATE EQUITY/ | 7,89 |
| Hervé Eloi Dominique Brailly, PhD | 0,91 |
| Mondher Mahjoubi | 0,78 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 235 | 237 | 215 | 210 | 179 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,29 | 0,24 | 0,06 | 0,24 | 0,29 |
Bilanz (in Mio. EUR) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 238 | 173 | 138 | 140 | 148 |
| Summe Anlagevermögen | 164 | 134 | 129 | 68 | 36 |
| Summe Aktiva | 401 | 307 | 267 | 208 | 184 |
Bilanz (in Mio. EUR) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 19 | 19 | 44 | 42 | 40 |
| Summe Fremdkapital | 184 | 151 | 160 | 154 | 132 |
| Summe Eigenkapital | 217 | 156 | 107 | 54 | 52 |
| Summe Passiva | 401 | 307 | 267 | 208 | 184 |
Adresse
| 117, Avenue de Luminy, 13009 Marseille | |
| Telefon | +33 (4) 30-30-30-30 |
| Internet | http://www.innate-pharma.com |
Management
|
Arvind K. Sood
Executive Vice President & President-US Operations |
|
Claire de Saint Blanquat
Secretary, VP-Legal & Corporate Affairs |
|
Eric Vivier
Chief Scientific Officer & Senior Vice President |
|
Frederic Lombard
Chief Financial Officer & Senior Vice President |
|
Gilles Brisson
Member-Supervisory Board |
|
Guillaume Gimonet
Senior Director-Launch Excellence |
|
Henry Wheeler
Vice President-Investor Relations & Communications |
|
Irina Staatz-Granzer
Chairman-Supervisory Board |
|
Jean-Yves Blay
Independent Member-Supervisory Board |
|
Jonathan Dickinson
Chairman-Executive Board & CEO |
|
Nicola Beltraminelli
Chief Development Officer & Vice President |
|
Odile Belzunce
Vice President-Compliance & Operations |
|
Odile Laurent
VP-Human Resources & Social Relations |
|
Olivier Martinez
Member-Supervisory Board |
|
Pascale Boissel
Independent Member-Supervisory Board |
|
Sally Bennett
Independent Member-Supervisory Board |
|
Samuel Dalens
Director |
|
Sonia Quaratino
Chief Medical Officer & Executive Vice President |
|
Véronique Chabernaud
Independent Member-Supervisory Board |
|
Yannis Morel
Chief Operating Officer & Executive Vice President |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
